Scott Fishman

Scott Fishman is a serial entrepreneur, investor, and market/technology analyst with over 30 years’ experience as a strategic advisor to the medical technology and pharmaceutical industries. He currently serves as CEO of Envisage (a division of Ethos LifeScience Advisors), which he founded to provide commercial guidance entrepreneurs, startups, and new product developers in the healthcare space. He is also an enthusiastic angel investor and sits on the Life Science Investment Advisory Committee for Ben Franklin Technology Partners, one of the nation's most successful technology-based economic development programs.

Actively involved in graduate education, Scott co-created and serves as program executive for the Commercialization Acceleration Program (CAP) at the Wharton School of the University of Pennsylvania. He also serves as a professor in marketing, management, negotiations, and strategic planning in the MBA program at Philadelphia University; co-teaches a commercialization course to bioengineering students at Drexel University; and lectures in translational therapeutics at the University of Pennsylvania Medical School. He earned his master’s degree in advertising from the University of Texas and bachelor’s degree in liberal arts from the University of Pennsylvania.